FDA Novel Drug Therapy Approvals for 2024 The table below is sourced from the running list of CDER’s novel drugs approvals for 2024. Novel Drug Approvals for 2024 | FDA No. Drug Name Active Ingredient Approval Date FDA–approved use on approval date* 50. Alhemo concizumab-mtci 12/20/2024 For routine prophylaxis to prevent bleeding episodes in hemophilia … Continue reading Novel Drug Approvals for 2024 | FDA